A Common Polymorphism near the ESR1 Gene Is Associated with Risk of Breast Cancer: Evidence from a Case-Control Study and a Meta-Analysis

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Guo, Hui ^a   Ming, Jie ^a   Liu, Chunping ^a   Li, Zhi ^a   Zhang, Ning ^a   Cheng, Hongtao ^b   Wang, Wei ^b   Shi, Wei ^a   Shen, Na ^a   Zhao, Qunzi ^a   Li, Dapeng ^a   Yi, Pengfei ^a   Wang, Longqiang ^a   Wang, Rui ^a   Xin, Yue ^a   Zhao, Xiangwang ^a   Nie, Xiu ^a   Huang, Tao ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUBEI CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE;

ADULT; ALLELE; ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; ESR1 GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; HIGH RISK POPULATION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; POPULATION RESEARCH; RISK ASSESSMENT;

ADULT; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; ESTROGEN RECEPTOR ALPHA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION GROUPS; PUBLICATION BIAS; RISK;

EID: 84871303378     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052445     Document Type: Article

References (51)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Nathanson KL, Wooster R, Weber BL, (2001) Breast cancer genetics: what we know and what we need. Nat Med 7: 552-556.
3. Easton DF, (1999) How many more breast cancer predisposition genes are there? Breast Cancer Res 1: 14-17.
4. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71.
5. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, et al. (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265: 2088-2090.
6. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39: 870-874.
7. Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, et al. (2008) Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci U S A 105: 4340-4345.
8. Kibriya MG, Jasmine F, Argos M, Andrulis IL, John EM, et al. (2009) A pilot genome-wide association study of early-onset breast cancer. Breast Cancer Res Treat 114: 463-477.
9. Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, et al. (2009) A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 41: 579-584.
10. Zheng W, Long J, Gao YT, Li C, Zheng Y, et al. (2009) Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 41: 324-328.
11. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, et al. (2010) Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 42: 504-507.
12. Cai Q, Long J, Lu W, Qu S, Wen W, et al. (2011) Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium. Hum Mol Genet 20: 4991-4999.
13. Fletcher O, Johnson N, Orr N, Hosking FJ, Gibson LJ, et al. (2011) Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. J Natl Cancer Inst 103: 425-435.
14. Kim HC, Lee JY, Sung H, Choi JY, Park SK, et al. (2012) A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study. Breast Cancer Res 14: R56.
15. Long J, Cai Q, Sung H, Shi J, Zhang B, et al. (2012) Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer. PLoS Genet 8: e1002532.
16. Shu XO, Long J, Lu W, Li C, Chen WY, et al. (2012) Novel genetic markers of breast cancer survival identified by a genome-wide association study. Cancer Res 72: 1182-1189.
17. Kiyotani K, Mushiroda T, Tsunoda T, Morizono T, Hosono N, et al. (2012) A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese. Hum Mol Genet 21: 1665-1672.
18. Clemons M, Goss P, (2001) Estrogen and the risk of breast cancer. N Engl J Med 344: 276-285.
19. Li N, Dong J, Hu Z, Shen H, Dai M, (2010) Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 121: 177-184.
20. Cai Q, Shu XO, Jin F, Dai Q, Wen W, et al. (2003) Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 12: 853-859.
21. Zheng W, Long J, Gao YT, Li C, Zheng Y, et al. (2009) Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 41: 324-328.
22. Stacey SN, Sulem P, Zanon C, Gudjonsson SA, Thorleifsson G, et al. (2010) Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. PLoS Genet 6: e1001029.
23. Campa D, Kaaks R, Le Marchand L, Haiman CA, Travis RC, et al. (2011) Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst 103: 1252-1263.
24. Zhong H, Prentice RL, (2010) Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases. Genet Epidemiol 34: 78-91.
25. Pabalan NA, (2010) Meta-analysis in cancer genetics. Asian Pac J Cancer Prev 11: 33-38.
26. Carlson RW, Allred DC, Anderson BO, Burstein HJ, Edge SB (2012) NCCN clinical practice guidelines for breast cancer (version 1.2012) http://www.nccn.org.
27. Lau J, Ioannidis JP, Schmid CH, (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826.
28. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
29. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
30. Thompson SG, Higgins JP, (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21: 1559-1573.
31. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J, (2005) A method for meta-analysis of molecular association studies. Stat Med 24: 1291-1306.
32. Mullen B MPBB (2001) Cumulative meta-analysis: A consideration of indicators of sufficiency and stability.: Personality and Social Psychology Bulletin. 1450-1462.
33. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
34. Egger M, Davey SG, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
35. Dai J, Hu Z, Jiang Y, Shen H, Dong J, et al. (2012) Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women. Breast Cancer Res 14: R17.
36. Sueta A, Ito H, Kawase T, Hirose K, Hosono S, et al. (2012) A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population. Breast Cancer Res Treat 132: 711-721.
37. Kim HC, Lee JY, Sung H, Choi JY, Park SK, et al. (2012) A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study. Breast Cancer Res 14: R56.
38. Long J, Cai Q, Sung H, Shi J, Zhang B, et al. (2012) Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer. PLoS Genet 8: e1002532.
39. Li G, Xiang YB, Courtney R, Cheng JR, Huang B, et al. (2011) Association of a single nucleotide polymorphism at 6q25.1,rs2046210, with endometrial cancer risk among Chinese women. Chin J Cancer 30: 138-143.
40. Long J, Shu XO, Cai Q, Gao YT, Zheng Y, et al. (2010) Evaluation of breast cancer susceptibility loci in Chinese women. Cancer Epidemiol Biomarkers Prev 19: 2357-2365.
41. Zheng W, Wen W, Gao YT, Shyr Y, Zheng Y, et al. (2010) Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. J Natl Cancer Inst 102: 972-981.
42. Cai Q, Wen W, Qu S, Li G, Egan KM, et al. (2011) Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry. Cancer Res 71: 1344-1355.
43. Han J, Jiang T, Bai H, Gu H, Dong J, et al. (2011) Genetic variants of 6q25 and breast cancer susceptibility: a two-stage fine mapping study in a Chinese population. Breast Cancer Res Treat 129: 901-907.
44. Stevens KN, Vachon CM, Lee AM, Slager S, Lesnick T, et al. (2011) Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res 71: 6240-6249.
45. Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D, et al. (2011) Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res 13: R110.
46. Han W, Woo JH, Yu JH, Lee MJ, Moon HG, et al. (2011) Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype. Cancer Epidemiol Biomarkers Prev 20: 793-798.
47. Jiang Y, Han J, Liu J, Zhang G, Wang L, et al. (2011) Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province. Breast Cancer Res Treat 128: 251-257.
48. Antoniou AC, Kartsonaki C, Sinilnikova OM, Soucy P, McGuffog L, et al. (2011) Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 20: 3304-3321.
49. Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, et al. (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20: 2310-2318.
50. Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B, Wu D, et al. (2010) Control of mammary stem cell function by steroid hormone signalling. Nature 465: 798-802.
51. Joshi PA, Jackson HW, Beristain AG, Di Grappa MA, Mote PA, et al. (2010) Progesterone induces adult mammary stem cell expansion. Nature 465: 803-807.